Phase 2 Lymphoseek(R) (Tilmanocept) Data Published Online In Annals Of Surgical Oncol
Neoprobe Corporation (NEOP), a diversified developer of innovative oncology surgical and diagnostic products, announced that results from a Phase II study of Lymphoseek® (Tilmanocept) have been published online in the Annals of Surgical Oncology and demonstrate the tracing agent's ability to identify tumor-draining lymph nodes in breast cancer and melanoma patients...
More... |
All times are GMT -7. The time now is 07:35 AM. |
Powered by vBulletin® Version 3.8.7
Copyright ©2000 - 2024, vBulletin Solutions, Inc.
Copyright HER2 Support Group 2007 - 2021